HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ciprofloxacin therapy for Mediterranean spotted fever.

Abstract
We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.
AuthorsD Raoult, H Gallais, P De Micco, P Casanova
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 30 Issue 4 Pg. 606-7 (Oct 1986) ISSN: 0066-4804 [Print] United States
PMID3789693 (Publication Type: Journal Article)
Chemical References
  • Ciprofloxacin
Topics
  • Adult
  • Boutonneuse Fever (drug therapy)
  • Ciprofloxacin (blood, therapeutic use)
  • Female
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: